An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer, according to results from a large international trial led by researchers at UCL and the London School of Hygiene & Tropical Medicine (LSHTM). For cervical cancer, 94% of deaths occur in low- and middle-income countries (350,000 women died in 2022). Ra ...
Latest News
Here you can find all the latest news from the UCL Innovative Clinical Trials Unit (formerly the MRC CTU at UCL).
A routine blood test offers new insight into survival in advanced prostate cancer
Analysis from the STAMPEDE trial shows that combining a PSA blood test with information about cancer burden at diagnosis predicts survival more accurately than PSA levels alone.
Young people living with HIV should take their HIV medicines daily, according to the BREATHER+ trial
BREATHER+ results published in The Lancet HIV confirm that taking HIV medicines every day without breaks remains the best way to keep the virus under control.
Hormone patches are as effective as injections for treating non-metastatic prostate cancer
Evidence from the PATCH and STAMPEDE trial networks broadens treatment options for people with prostate cancer who are starting long-term hormone therapy.
Advanced imaging tools could help detect tuberculosis earlier
New findings from UCL and University of Cape Town show that PET-CT scans and AI-read X-Rays can detect evidence of TB in the lungs as much as 5 years before final diagnosis.